Table 3.
Group statistics for MIDAS scores after treatment with Erenumab and Topiramate.
| Comparative Groups | n | Mean | SD | Std. Error Mean | |
|---|---|---|---|---|---|
| MIDAS After | Erenumab | 52 | 5.79 | 2.14 | 0.3 |
| Topiramate | 56 | 6.2 | 2.5 | 0.33 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.